Vaccine News and Research

Latest Vaccine News and Research

UIC clinical trial to soon test a vaccine for COVID-19

The University of Illinois at Chicago will soon test a vaccine for COVID-19.

15 Jun 2020

BCG vaccination strengthens the immune system

A tuberculosis vaccine developed 100 years ago also makes vaccinated persons less susceptible to other infections. While this effect has been recognized for a long time, it is not known what causes it.

15 Jun 2020

Combination of nelfinar and amodiaquine shows promise for treating COVID-19

Six months into the COVID-19 pandemic, more than 7.4 million people have been infected, and more than 410 000 have died. As yet, there is no treatment or vaccine for the disease.

15 Jun 2020

Tumor-resident T cell levels underlie improved survival in throat cancer patients

Research led by the Centenary Institute has discovered that immune cells accumulating within the tumor environment, called tumour-resident T cells, are a critical determinant in survival rates of patients suffering from throat cancer.

15 Jun 2020

Study shows 1 in 15 parents is hesitant about routine childhood vaccines

A national study measuring parental attitudes toward vaccinations found 6.1% were hesitant about routine childhood immunizations while nearly 26% were hesitant about the influenza vaccine.

15 Jun 2020

Tuberculosis and polio vaccines may offer temporary protection against SARS-CoV-2

As the world grapples with the coronavirus disease (COVID-19) pandemic, scientists race to develop an effective vaccine to protect against the deadly SARS-CoV-2 virus. While potential vaccines are still being developed and tested, researchers propose that existing vaccines could give the immune system a temporary boost to ward off infection.

14 Jun 2020

Glycans "lock and load" the SARS-CoV-2 spike protein for infection

A new study by scientists from the University of California San Diego, USA and Maynooth University, Ireland and published on the preprint server bioRxiv* in June 2020 reports preliminary results showing that the spike protein of the SARS-CoV-2, as well as its glycan coat, has “hitherto unseen functional and structural” properties. These may be useful in designing novel therapeutics to target this molecule.

14 Jun 2020

Effect of human genes on severity and infectivity of SARS-CoV-2

Now, a new paper published on the preprint server medRxiv* reports the results of an analysis of the association between the genetic variants in the patients and the clinical progression of the disease. The study included 332 patients hospitalized with COVID-19 in a single-center, with widely varying laboratory and clinical features. There were 25, 12, and 17 patients with asymptomatic, mild, and critical disease.

14 Jun 2020

Early neutralizing response to SARS-CoV-2 dominated by IgA antibodies

Researchers from France and the U.S. demonstrated how severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection could induce an early and vigorous virus-specific IgA response that paves the way for the production of SARS-CoV-2 IgG antibodies, with even better neutralizing properties. Their paper is currently available on the medRxiv preprint server.

14 Jun 2020

NIAID and Moderna scientists describe SARS-CoV-2 vaccine development

Researchers at the National Institute of Allergy and Infectious Diseases and Moderna Inc., have described the potent neutralizing effects of a candidate vaccine for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that is currently being tested in a phase II trial.

14 Jun 2020

Survey: UK public understand that fast-tracking COVID-19 treatments could bring greater risks

The majority of the British public understand that fast-tracking vaccines, treatments and tests for COVID-19 could bring greater risks, according to a survey commissioned by law firm Hill Dickinson’s Life Sciences practice.

12 Jun 2020

Does COVID-19 injure the placenta of pregnant women?

News-Medical speaks to Dr. Jeffery Goldstein about whether COVID-19 is damaging the placentas of pregnant women and what women can do to protect themselves.

12 Jun 2020

Drug-like molecules offer a promising treatment for COVID-19

A team of researchers at the University of Georgia has successfully demonstrated that a set of drug-like small molecules can block the activity of a key SARS-CoV-2 protein - providing a promising path for new COVID-19 therapeutics.

12 Jun 2020

Facemasks will prevent COVID-19 in the "new normal"

The coronavirus disease (COVID-19) has left many countries grappling with high infection rates. The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has negatively impacted societies and economies. Now though, many countries are starting to lift restrictions to prepare for a "new normal."

12 Jun 2020

UNC scientists develop new kind of antibody test for COVID-19

As the COVID-19 pandemic continues with many thousands of new infections reported each day, there is a need for widely applicable surveillance testing to gain a better understanding of infection rates, especially the number of infections in people with mild or no symptoms, who can still be carriers.

11 Jun 2020

WVU researchers develop new diagnostic and antibody tests for COVID-19

COVID-19 tests are in short supply. The companies that make the necessary chemicals--called reagents--can't keep up with demand. But researchers at West Virginia University are developing new tests on their own to identify who has COVID-19 now and who had it in the past but recovered.

11 Jun 2020

New insight could aid in the development of universal vaccines for respiratory viruses

A significant site of damage during COVID-19 infection is the lungs. Understanding how the lungs' immune cells are responding to viral infections could help scientists develop a vaccine.

11 Jun 2020

Computational approach to design peptide-based vaccine against SARS-Cov-2

There are currently no licensed vaccines available for COVID-19. While several antiviral drugs have been tested, none has proved to be completely effective against the disease.

11 Jun 2020

Article calls for international governance system to oversee access to Covid-19 vaccines, treatments

Human challenge trials to test the efficacy of vaccine candidates against SARS? CoV? 2, the novel coronavirus behind COVID? 19, could save considerable time and many lives.

11 Jun 2020

A lead compound can significantly reduce or eliminate toxoplasmosis and malaria

Toxoplasma gondii infection is one of the most frequent parasitic infections of humans. This parasite is present in the brain of an estimated two billion people--about 40 percent of all humans on earth. It is endemic throughout the world, causing water and food-borne epidemics that result in toxoplasmosis.

10 Jun 2020

Vaccine News and Research

Latest Vaccine News and Research

UIC clinical trial to soon test a vaccine for COVID-19

BCG vaccination strengthens the immune system

Combination of nelfinar and amodiaquine shows promise for treating COVID-19

Tumor-resident T cell levels underlie improved survival in throat cancer patients

Study shows 1 in 15 parents is hesitant about routine childhood vaccines

Tuberculosis and polio vaccines may offer temporary protection against SARS-CoV-2

Glycans "lock and load" the SARS-CoV-2 spike protein for infection

Effect of human genes on severity and infectivity of SARS-CoV-2

Early neutralizing response to SARS-CoV-2 dominated by IgA antibodies

NIAID and Moderna scientists describe SARS-CoV-2 vaccine development

Survey: UK public understand that fast-tracking COVID-19 treatments could bring greater risks

Does COVID-19 injure the placenta of pregnant women?

Drug-like molecules offer a promising treatment for COVID-19

Facemasks will prevent COVID-19 in the "new normal"

UNC scientists develop new kind of antibody test for COVID-19

WVU researchers develop new diagnostic and antibody tests for COVID-19

New insight could aid in the development of universal vaccines for respiratory viruses

Computational approach to design peptide-based vaccine against SARS-Cov-2

Article calls for international governance system to oversee access to Covid-19 vaccines, treatments

A lead compound can significantly reduce or eliminate toxoplasmosis and malaria

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Newsletters you may be interested in